Systems Pharmacology and Microbiome Dissection of Shen Ling Bai Zhu San Reveal Multiscale Treatment Strategy for IBD

Figure 1

Compound-target-disease-pathway network. (a) Compound-target network of SLBZS consisting of 171 nodes (97 compounds and 74 potential targets) and 330 edges. (b) Target-disease network including 73 candidate targets and 4 diseases. (c) Target-pathway network including 59 candidate targets and 47 KEGG pathways.

(a)

(b)

(c)